LM-302
Phase 3- Indications
- Cancer
Company intelligence / Profile preview
Lixin Pharmaceutical
Shanghai, Shanghai, Chinalixinpharm.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Lixin Pharmaceutical is a clinical-stage biotech company with a robust pipeline of innovative biologics for oncology. Its lead asset LM‑108 targets CCR8 in tumor-infiltrating regulatory T cells and is in Phase II trials with promising safety/efficacy data. The company has established partnerships with major pharma companies like Merck and SINO BIOPHARM to advance its bispecific antibodies and ADCs targeting solid tumors. Early results show strong potential in difficult-to-treat cancers; the company’s platforms enable rapid expansion of its R&D pipeline[6][7].
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugateSmall molecule
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Merck/MSDSINO BIOPHARM
Beyond the preview
Go deeper on Lixin Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lixin Pharmaceutical.